The latest closing stock price for Intra-Cellular Therapies as of February 20, 2025 is 128.54.
An investor who bought $1,000 worth of Intra-Cellular Therapies stock at the IPO in 2014 would have $7,569 today, roughly 8 times their original investment - a 21.57% compound annual growth rate over 11 years.
The all-time high Intra-Cellular Therapies stock closing price was 128.60 on February 19, 2025.
The Intra-Cellular Therapies 52-week high stock price is 128.77, which is 0.2% above the current share price.
The Intra-Cellular Therapies 52-week low stock price is 63.30, which is 50.8% below the current share price.
The average Intra-Cellular Therapies stock price for the last 52 weeks is 80.68.
An investor who bought $1,000 worth of Intra-Cellular Therapies stock at the IPO in 2014 would have $7,569 today, roughly 8 times their original investment - a 21.57% compound annual growth rate over 11 years.
The all-time high Intra-Cellular Therapies stock closing price was 128.60 on February 19, 2025.
The Intra-Cellular Therapies 52-week high stock price is 128.77, which is 0.2% above the current share price.
The Intra-Cellular Therapies 52-week low stock price is 63.30, which is 50.8% below the current share price.
The average Intra-Cellular Therapies stock price for the last 52 weeks is 80.68.